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1. Introduction 
1.1 Tuberculosis and immune system 
Mycobacterium tuberculosis is a serious threat to humankind, with over 8 million cases of 
tuberculosis (TB) annually, killing almost 3 millions of people per year around the world 
(WHO, 2008). Moreover, side effects from first-line anti-TB drugs can cause significant 
morbidity, and compromise treatment regimens for TB (Yee et al., 2003). Most healthy 
individuals are able to control TB infection with a vigorous immune response, halting the 
progression of the disease, but not necessarily eradicating the microorganism (McKinney, 
2000).  
The bacterium resides within macrophages, allowing them to resist the antimicrobial 
effector mechanisms of the host (Raupach & Kaufmann 2001). Macrophages constitute one 
of the main phagocyte cells of the immunological system and they are the first cells involved 
in an immunological response. Part of their effectiveness is due to the production of nitric 
oxide (NO), hydrogen peroxide (H2O2) and cytokines, as well as phagocytosis of strange 
particles (Allavena et al., 2008; Carlos et al., 2004; Keil, 1999). Thus, the elimination of 
tuberculosis bacillus is involved in the production of these effectors molecules from immune 
system. 
The hydrogen peroxide, generated by macrophages in a reaction catalyzed by an NADPH 
oxidase, was the first identified effector molecule that mediated mycobacteriocidal effects of 
mononuclear phagocytes (Lopes et al., 2005; Walker & Lowrie, 1981). In spite of several 
studies have indicated significant M. tuberculosis resistance to oxidative stress in vitro and in 
vivo, a recent study showed that H2O2 induced the complete sterilization of the cultures of 
M. tuberculosis by 24 h, after the exposition to 50mM of H2O2 (Volskuill et al., 2011).  
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NO formed by the action of the inducible form of nitric oxide synthase (iNOS) reacts with 
oxygen radical forming RNI. NO and related RNI have been reported to possess 
antimycobacterial activity (Chan et al., 2004; Kwon, 1997). Although the role of NO in 
human tuberculosis remains unsettled evidence supporting its importance has come from a 
variety of areas (Nathan & Shiloh, 2000) including the demonstration that human 
granulomas contain iNOS, endothelial-NOS and nitrotyrosine, a compound whose 
accumulation indicates production of NO (Nathan, 2002). Additionally, the ability of human 
alveolar macrophages to kill M. tuberculosis is dependent on the activity of iNOS and the 
human macrophages taken from healthy subjects latently infected with M. tuberculosis 
produce NO controlling the growth of the bacteria (Yang et al., 2009). The presence of NO 
within human granulomas could contribute to host resistance since in vitro experiments 
demonstrate direct RNS-mediated bacteriostatic (Firmani & Riley, 2002; Ouellet et al., 2002; 
Voskuil et al., 2003) and bactericidal activity (Nathan, 2002). Mice deficient in both phox and 
iNOS are much more susceptible to M. tuberculosis infection than either mutant alone which 
would indicate that RNS and ROS protect the host in a partially redundant fashion (Shiloh 
& Nathan, 2000; Volskuill et al., 2011). 
TNF-α is a cytokine that plays multiple roles in immune and pathologic responses in 
tuberculosis, also required for acute infection control (Babbar et al., 2006; Flynn et al., 1995; 
Palladino et al., 2003). The pro-inflammatory cytokine TNF-α produced by activated 
macrophages is a central contributor to the immune response against M. tuberculosis (Flynn, 
1986; Marino et al., 2007 ). The role of TNF is of clinical interest due to the association of 
anti-inflammatory TNF-α blocking drugs with reactivation of latent TB in humans (Keane et 
al., 2001; Wintrop,2006). This cytokine has multiple immunological functions during 
infection with M. tuberculosis: It has a direct role in immune cell recruitment via up-
regulation of endothelial adhesion molecules (Zhou, et al., 2007) facilitating transendothelial 
migration of immune cells to the site of infection. TNF-α regulates production of 
chemokines by macrophages (Algood et al., 2006; Roach et al., 2002); chemokines can further 
induce transendothelial migration and coordinate recruitment of immune cells within the 
tissues. TNF-α activates macrophages in conjunction with the cytokine IFN-γ (Flesch & 
Kaufmann 1986; Roock et al., 1986; Carlos et al., 2009) such activated macrophages can kill 
intracellular mycobacteria. TNF-α can also induce necrotic or apoptotic cell death in 
macrophages (Laster et al., 1988) that is promoted by TB infection (Keane, et al., 2001). 
1.2 Plant with antimycobacterial and immunostimulating activity 
With proposal to stimulate the immune system, some plants can be used in collaboration 
with the standards drugs for the treatment of tuberculosis. Moreover, there are a lot of 
plants that can be able to presenting an antimycobacterial activity. 
It is possible to assign this effect to the substances contained in its structure which are 
responsible for protecting the plant structure from aggressive agents in what concerns the 
active ingredients of plants with an antimicrobial character. Most of these substances are 
part of the secondary metabolites which consist of substances produced by plants which are 
not vital and involved in metabolic mechanisms. Flavonoids, tannins, terpenes, alkaloids, 
phenolic compounds, etc are examples of secondary metabolites. Thereby, many of these 
compounds protect the vegetal structure against external aggression such as insects, solar 
radiation, fungi, bacteria and viruses (Heldt, 1997).  
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Terpenoids are known as natural insecticides. This class also includes limonoids, limonene 
and myrcene which plays an important role in the protection of the plants against insects. 
Some terpenoids have already been tested and have manifested an activity against 
mycobacterium (Cantrell et al., 2001). Terpenes are composed by basic units of active 
isoprene isopentenilpirofosfatou, and originate triterpenes and sesquiterpenes previously 
mentioned in literature as substances with bacterial features (Januario et al., 2002; Pietro et 
al., 2000). 
Essential oils such as geraniol, citronellol, cineole and other genus Eucalyptus L'Herit, are 
recognized as bactericide (Hinou et al. 1989; Leite et al., 1998). The alkaloid obtained from 
extracts of leaves of A. Vasic, vasicine acetate and 2-acetyl benzyl amine showed promising 
antimycobacterial activities in several strains of M. tuberculosis (Gupta et al., 2010). 
The endophytic fungi are microorganisms capable of producing potentially bioactive 
metabolites. These molecules may have hormonal, antibiotic or antitumor activities and 
other biological functions of enormous industrial and biotechnology interest. Tan and Zou 
(2001) examined the diversity of metabolites from isolated endophytic fungi and reported 
the isolation of substances belonging to different structural groups such as steroids, 
xanthones, phenols, isocoumarins, alkaloids, quinones, furandionas, terpenoids, peptides, 
cytochalasins and aliphatic compounds. 3-D citosporona, fomopsolida and the acid 
“coletótricose” stand out for their antibacterial activity shown in several studies (Brady et al. 
2000; Zou et al., 2000). 
Considering the importance of immunomodulation in the treatment of tuberculosis, the 
activation of some components of the immune system is a great advantage when it is 
associated with the bacterial/bacteriostatic activity of the plants.  As examples of substances 
which have immunostimulant and antimicrobial actvities associated, the lectin derived from 
Synadenium carinatum has an important stimulatory activity of granulocytes and NK cells. It 
is also able to stimulate the expression of TNF-α, IL-1 and iNOS in murine peritoneal 
macrophages (Cardoso, 2006). This activity is due, partially, to the presence of tannins. This 
class of secondary metabolites can stimulate the production of IL-1 and TNF-α in 
macrophages as well as having a significant antimicrobial activity with MIC <100μg/mL 
against M. tuberculosis (Lawal et al., 2011;  Miyamoto et al. 1993). 
Scutellaria baicalensis has also an immunostimulant action combined with antibacterial 
activity. In addition to the activity against M. tuberculosis, S. baicalensis employs a toxic 
activity against cholera, typhoid, streptococcus, E. coli, Pneumococcus, Klebsiella pneumoniae, 
Proteus vulgaris Mycobacterium tuberculosis, Pseudomonas aeruginosa and Corynebacterium 
diphtheria. This plant induces the production of TNF-α possibly due to the effect of flavonoid 
wogonin (Chang et al. 1986; Franzblav & Cross 1986; Huang, 1993; Jen et al., 2002). This 
mediator was also investigated as TNF-α acts in the production of nitric oxide. The results 
showed that low concentrations of wogonin induce the production of nitric oxide and high 
concentrations inhibit the production (Jen et al., 2002).  
Similarly, Glycyrrhiza glabra evinced antimicrobacterial activity in the concentration of 
0.5mg/mL. After a phytochemical analysis, the tuberculosis which is toxic to the bacilli at 
concentrations of 0.029 mg / mL (Gupta et al., 2008) was attributed to the activity against M. 
glabridin. Regarding the immunomodulatory activity, it has been observed that the extract of 
Glycyrrhiza glabra intensely activated granulocytes and NK cells (Cheell et al., 2010). 
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Our research group studied Indigofera suffruticosa Miller (Fabacesae) with the aim to 
collaborate with the discovery of alternatives treatments for tuberculosis. Since at this 
moment there is no new drug generation able to eliminate the bacillus and simultaneously 
stimulate the immune system we investigated the antimycobacterial and immunological 
activity of methanol (METH) and dichloromethane (DCM) extracts of I. suffruticosa.  
I. suffruticosa  is found in tropical and subtropical areas and is well adapted to growth in 
semi-arid regions and soils of low fertility (Paiva, 1987). A chemical investigation of extracts 
of leaves of I. suffruticosa in Natural Products Alert (NAPRALERT) and Chemical Abstracts 
databases has revealed the presence of alkaloids, flavanoids, steroids, proteins, 
carbohydrates and indigo. Some recent reports have demonstrated the in vitro bioassay 
activity of plant-derived terpenoids against M. tuberculosis (Cantrell et al., 2001; Higuchi et 
al., 2008). The literature also reports the antimycobacterial activity of many classes of natural 
products: such as alkanes, phenolics, acetogenic quinines, flavonoids, triterpenes, 
flavonones and chalcones (Copp, 2003; Higuchi et al., 2008; Pavan et al., 2009). Previous 
results demonstrated that indigotin alkaloid can enhance macrophage functions and 
therefore contribute to the host defense against pathogens and tumors (Lopes et al., 2006). 
2. Materials and methods 
2.1 Plant material and samples 
Aerial parts of I. suffruticosa were collected in Rubião Junior, Botucatu city, São Paulo State, 
Brazil, and identified by Prof. Dr. Jorge Yoshio Tamashiro. The immunological assays were 
performed as soon as the plant was collected. A voucher specimen (HUEC 129598) was 
deposited at the Herbarium of the Universidade Estadual de Campinas (Unicamp), 
Campinas, SP, Brazil. Aerial parts of I. suffruticosa (1.1 Kg) were dried Activity of the I. 
suffruticosa (40°C), powdered and extracted exhaustively at room temperature with 
dichloromethane and methanol, successively. Solvents were evaporated at 40°C under 
reduced pressure to afford the DCM (15.2 g) and METH (30.0 g) extracts. Each extract was 
first solubilized in dimethyl sulfoxide (DMSO) and then diluted in an appropriated culture 
medium, RPMI-1640 for the immunological assays and Middlebrook 7H9 for the 
determination of antimycobacterial activity (62.5-4000 μg/mL).  
2.2 Peritoneal macrophages 
Peritoneal macrophages Thioglycollate-elicited PEC were harvested from Swiss mice using 
5.0 mL of sterile PBS, pH 7.4. The cells were washed twice by centrifugation at 200 g for 5 
min at 4ºC and re-suspended in RPMI-1640 medium (Sigma). The adherent cells were 
obtained by incubation for 1 h at 37ºC in an atmosphere of air/CO2 (95:5, v/v) (Forma 
Scientific) and, incubated with LPS or RPMI-1640 medium. This protocol was in agree with 
the regulations of Research Ethics Committee (# 01/2005). 
2.3 MTT assay for cell viability 
PEC (5x106 cells/mL) was re-suspended in RPMI- 1640 medium. The suspension (100 μL) 
and the extracts (100 μL) were added to each well of a 96-well tissue culture plate and they 
were incubated for 24 h. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide 
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(MTT) colorimetric assay was performed as described by Mosmann (1983) . Only cells and 
culture medium (RPMI- 1640) were used as a control that corresponds to 100% of 
macrophages viability. 
2.4 Measurement of H2O2 production 
Hydrogen peroxide measurement the adherent cells of PEC (2x106cells/mL) was measured 
using the horseradish peroxidase-dependent phenol red oxidation microassay (Pick & 
Mizel, 1981). Phorbol myristate acetate (PMA, Sigma, St. Louis, MO) were used as a positive 
control. 
2.5 Measurement of NO production 
NO measurement the adherent cells of PEC (5x106cells/mL) was mensured using Griess 
reagent (Green et al., 1982). E. coli O111B lipopolysaccharide (LPS – 1 μg/mL) solution were 
used as positive control. 
2.6 Measurement of TNF-α production  
The determination of TNF-α in the supernatants was based in its property to destroy L929 
tumoral cell line (mouse tumour fibroblast) Carlos et al. (1994). LPS (1 μg/mL) was used as a 
positive control. 
2.7 Determination of antimycobacterial activity by MABA  
The minimum inhibitory concentration (MIC) of DECE was determined against M. 
tuberculosis H37Rv (American Type Culture Collection 27294) in Middlebrook 7H9 medium 
using the Microplate Alamar Blue Assay - MABA (Collins & Franzblau, 1997). For standard 
test, the MIC value of Isoniazid (Sigma) was determined each time. The acceptable MIC of 
Isoniazid ranged from 0.015 to 0.05 μg/mL. 
2.8 Statistical analysis 
The results are expressed as means ± SD of five experiments. One-way ANOVA with 
Dunnett’s post test was performed using GraphPad InStat (San Diego, California, US) with 
the level of significance set at p < 0.05. 
3. Results and discussion 
Actually, TB multiple drug resistance has become a major threat worldwide and thus calls 
for an urgent search for new and effective treatments for this deadly disease. Naturally 
occurring compounds as extracts from plants have indicated that inhibitory activity against 
M. tuberculosis is widespread in nature (Okunade et al., 2004).  
The cytotoxicity effect of the extract was evaluated by the determination of MTT (a 
tetrazolium salt: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (Mosmann, 
1983) (Table 1). The index of cytotoxicity 50 (IC50) found was in the concentration of 
200μg/mL. 
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Extracts Viability (%) 
Control 100 ± 0,00 
600a 
400a 
200a 
100a 
15,73 ± 1,90 
30,29 ± 4,32 
55, 29 ± 1,36 
71, 57 ± 1, 82 
Table 1. Effect of methanolic and dichloromethane extracts of Indigofera suffruticosa  on the 
viability of peritoneal macrophages. a- µg/mL 
This study evaluated the antimycobacterial activity the extracts of I. suffruticosa and its 
action in innate immune system. The antimycobacterial activity of METH and DCM is 
presented in table 2. Gu et al. (2004) considered active plant extracts with MIC value ≤128 
μg/mL. Thus we considered a promising result the MIC of 125 μg/mL found in METH 
crude extract.  
 
 Methanolic Dichloromethane Isoniazida 
MIC 125b 1000b 0,05b 
Table 2. Minimal inhibitory concentration (MIC) in presence of methanolic and 
dichloromethane extracts of the plant Indogofera suffruticosa. aStandard drug, bg/mL. 
The extracts presented a high production of nitric oxide with statistically significant values 
compared to the negative control (p<0,001). The amount of NO produced by the METH 
extract (105, 99 μmol/5.105 cells) was larger than the production of DCM extract (58, 9 
μmol/5.105 cells) (Fig. 1). 
 
Fig. 1. Induction of nitric oxide. 
The results regarding of TNF-α confirmed a significant production of this cytokine at levels 
near the positive control (252,7 and 234,6 units/mL, METH and DCM extracts, respectively) 
confirming a correlation between the synthesis of TNF-α and NO (Fig. 3) (Bogdan et al., 
1991; Carli et al., 2009). 
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Fig. 2. Induction of tumor necrosis factor-α. 
I. suffruticosa did not produce significant amounts of H2O2 when compared with control 
negative (p>0,05), METH (0,59 nmols/2.105cells) and DCM (3,3 nmols/2.105cells) (Fig. 3). 
This fact can be justified by the presence of tannins, such as gallic acid in extracts of I. 
suffruticosa. This class of substances has been showed an antioxidant potential being 
responsible for the scavenger of free radicals such as hydrogen peroxide. (Akira et al., 
2002). 
 
Fig. 3. Induction of hydrogen peroxide. 
Thus, this screening suggests that both extracts of the I. suffruticosa promoted the activation 
of the macrophages. The significant production of studied mediators (NO and TNF-α) by 
activated macrophages in presence of I. suffruticosa is very important, since macrophages 
produces several effector molecules that can enhance or restore the ability of the innate 
immune system to fight against TB infection.  
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Nitric oxide (NO) formed by the action of the inducible form of nitric oxide synthase (iNOS) 
reacts with oxygen radical forming RNI. NO and related RNI have been reported to possess 
antimycobacterial activity (Kwon, 1997). Phagocytes kill intracellular organisms during an 
initial oxidative phase dependent on NADPH oxidase  followed by a prolonged nitrosative 
phase during which bacterial growth is inhibited by iNOS (Nathan & Shiloh, 2000).There are 
several potential mechanisms that can explain how NO may affect microbial life-cycle. NO 
and other RNI can modify bacterial DNA, protein and lipids at both the microbial surface 
and intracellularly. They can alter cytokine production and induce or prevent apoptosis of 
host cells by controlling caspase activity (Raupach & Kaufmann, 2001). 
M. tuberculosis strongly induces the release of several cytokines during infection. Tumor 
necrosis factor-α (TNF-α) is a cytokine that plays multiple roles in immune and pathologic 
responses in tuberculosis, also required for acute infection control (Flynn et al., 1995). It 
plays a major role in the recruitment of inflammatory cells to the site of infection and in the 
formation and maintenance of granulomas (Gaemperli et al., 2006). This cytokine is 
necessary for optimal co-ordination of both the differentiation of specific T cells to secrete 
the appropriate T helper 1 cytokines and the development of granulomas in which activated 
macrophages restrict mycobacterial growth (Ehlers, 2003). TNF-α is required for control of 
latent TB and it is also a key element for activating macrophages to produce iNOS and thus 
in maintaining the pathway for generating NO and preventing reactivation of the disease 
(Adams et al., 1995). 
4. Conclusion 
We suggest that the extract may be an important bactericidal source against M. tuberculosis 
once the same has natural origin and do not present the toxic effects provoked by the drugs 
current used in the treatment of tuberculosis. Moreover, a possible association with 
traditional drugs can be suggested considering that the most of standard drugs do not 
present the same simultaneous effect microbiological and immunological of the extract here 
tested. These results described here highlight the importance of conducting an in-depth 
study of the species of the Brazilian biome, and show the great potential of it’s biodiversity 
in the treatment of infection diseases. 
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